Biochemical Predictors of Elevated Blood Pressure and Cardiometabolic Risk in School-Aged Children: A Cross-Sectional Study
Keywords:
N\AAbstract
Background: Hypertension is emerging in children, mainly due to obesity and lifestyle changes. Early biochemical markers may help detect cardiometabolic risk before clinical disease appears.
Objective: To determine the association between selected biochemical markers and elevated blood pressure in school-aged children.
Methods: A cross-sectional study was conducted among 220 children aged 8–14 years from three schools. Blood pressure was categorized according to age- and height-specific percentiles. Fasting blood samples were analyzed for lipid profile, fasting glucose, fasting insulin, HOMA-IR, uric acid, high-sensitivity CRP (hs-CRP), and vitamin D levels. Anthropometry and BMI percentiles were recorded.
Results:
Pre hypertension and hypertension were found in 14.5% and 6.8% of children, respectively. Mean systolic BP was higher in children with high LDL (112.7 ± 8.5 mmHg) compared to normal LDL (105.4 ± 7.9 mmHg, p < 0.01). Insulin resistance (HOMA-IR > 2.5) was present in 28% of participants. Children with elevated HOMA-IR had significantly higher systolic BP (113.6 ± 9.1 mmHg) compared to those without insulin resistance (104.9 ± 7.5 mmHg, p < 0.001). Uric acid showed a moderate positive correlation with systolic BP (r = 0.42). Elevated hs-CRP (>3 mg/L) was detected in 18% of participants and was associated with higher BMI and BP. Vitamin D deficiency (<20 ng/mL) was common (62%) but showed a weak association with BP.
Conclusion: LDL cholesterol, insulin resistance, uric acid, and hs-CRP are strong biochemical predictors of elevated blood pressure in children. Routine screening in overweight and obese children may help identify early cardiometabolic risk
Downloads
References
1. Munir U, Naeem M, Shafiq U, Ahmad I, Rehman FU, Zafar MA, et al. Early detection of cardiovascular risk in pediatric populations: Are we doing enough compared to adult protocols? Pakistan J Health Sci. 2025;6(8):3–8.
2. Akhtar S, Khan S, Aziz N, Imran M, Samad Z, Iqbal R, et al. Obesity and risk of hypertension in preadolescent urban school children: insights from Pakistan. J Health Popul Nutr. 2024;43(1):89.
3. Rehman FU, Shahnawaz K, Zahoor F, Madni B, Imran M, Naveed M. Prevalence and risk factors of systemic hypertension among children. Prof Med J. 2022;29(5):667–670.
4. Ain Q, Nawaz A, Khan M, Sikonja J, Batool H, Zaheer R, et al. Dyslipidaemia among children and adolescents in Pakistan: a five-year retrospective cohort study based on laboratory data. Lipids Health Dis. 2025;24(1):110.
5. Chung YL, Rhie YJ. Metabolic syndrome in children and adolescents. Ewha Med J. 2022;45(4):e13.
6. Dalili S, Hassanzadeh Rad A, Salkhori O, Dabbaghi S, Karambin M, Badeli H, et al. Potentials of hyperuricemia and insulin levels in predicting hypertension in obese children: a cross-sectional study. J Compr Ped. 2023;15(1):e139577.
7. Zhu H, others. Associations of triglyceride-glucose index and metabolic score for insulin resistance with various hypertension phenotypes in children and adolescents: results from the 2017 China Nutrition Survey. Front Endocrinol. 2025;16:1595097.
8. Basit A, Hakeem R, Hydrie MZI, Ahmedani MY, Masood Q. Relationship among fatness, blood lipids, and insulin resistance in Pakistani children. J Health Popul Nutr. 2005;23(1):34–43.
9. Maffeis C, Morandi A. Management of metabolic syndrome in children and adolescents. Nutrients. 2022;14(17):3583.
10. Podeanu MA, Bocsan IC, Samasca G, Deleanu D. C-reactive protein as a marker of inflammation in children: a review. J Pediatr Child Health. 2023;59(6):728–735.
11. Huang D, Ma J, Pan Q, Xu J, Wang F, Liu Y. CRP-to-HDL ratio and hyperuricemia risk in metabolic disorders. Front Endocrinol. 2025;16:1619370.
12. Karambin HB, Hassanzadeh Rad A, Salkhori O, Dabbaghi S, Karambin M. Hyperuricemia and insulin levels in predicting pediatric hypertension. J Compr Ped. 2023;15(1):e139577.
13. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904.
14. Okuyan O, Bideci A, Çamurdan O, Cinaz P. Vitamin D status and cardiometabolic markers in obese children. Nutrients. 2024;16(17):3005.
15. Krajewska M, Strączkowski M, Krętowski A, Rucka A, Adamska A. Chemerin, vitamin D, and metabolic profile in obese youth. Front Endocrinol. 2023;14:1143755.
16. Trinh S, Wilson L, Kohn M. Utility of surrogate markers of insulin resistance in children: a systematic review. Pediatr Diabetes. 2022;23(3):339–349.
17. Köksal T, Bayram Y, Ustebay S, Karakoyun M, Aslantekin F. Vitamin D deficiency and metabolic indicators in obese Turkish children. Nutr Hosp. 2025;42(1):68–75.
18. Namakin K, Sharifzadeh G, Jafari F, Mohammadi M. Effects of vitamin D supplementation on metabolic parameters in adolescents. J Clin Med. 2021;10(6):1204.
19. Savastio S, Cadario F, Genoni G, Bellone S, Bona G. Vitamin D and cardiovascular risk in children: a systematic review. Int J Mol Sci. 2020;21(10):3536.
20. Oliveira AC, Mello MM, Carvalho DF, Lima LN, Vieira EC. ALT and hs-CRP associations with cardiometabolic risk factors in youth. J Pediatr Gastroenterol Nutr. 2008;46(3):294–300.
21. National Heart, Lung, and Blood Institute (NHLBI). Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. 2012.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
